ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PVG Premier Veterinary Group Plc

34.50
0.00 (0.00%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Premier Veterinary Group Plc LSE:PVG London Ordinary Share GB00BSZLMS59 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.50 32.00 37.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ark Therapeutics Group PLC Results of General Meeting (5202Z)

11/12/2014 12:43pm

UK Regulatory


Premier Veterinary (LSE:PVG)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Premier Veterinary Charts.

TIDMAKT

RNS Number : 5202Z

Ark Therapeutics Group PLC

11 December 2014

ARK THERAPEUTICS GROUP PLC

Results of General Meeting

London, UK, 11 December 2014 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that at the Company's General Meeting held earlier today all resolutions were duly passed. A summary of the votes lodged by proxy is set out below:

 
 No   Resolution                 Votes for         %     Discretion        %         Votes        %     Votes withheld 
                                                                                   against 
      Proposed transfer 
 1     to standard list         73,699,781     92.23      6,189,396     7.75        15,237     0.02             38,050 
      Adoption of 2014 
       Executive Option 
 2     Plan                     73,692,058     92.25      6,175,245     7.73        17,609     0.02             57,552 
      Adoption of 2014 
 3     EMI Plan                 73,692,058     92.25      6,175,245     7.73        17,609     0.02             57,552 
      Approval of 
      Directors' 
      remuneration 
 4    policy                    68,157,170     85.39      6,175,245     7.73     5,486,957     6.87            122,552 
      Approval of the 
 5     Rule 9 waiver            73,703,875     99.74        175,245     0.24        17,309     0.02             46,053 
      Approval of the 
       Terms of the 
 6     Subscription             73,639,630     92.24      6,175,245     7.73        17,309     0.02            110,550 
      Authority to 
 7     allot shares             73,631,243     92.18      6,233,362     7.80        17,309     0.02             60,550 
      Disapplication 
       of pre-emption 
 8     rights                   73,627,226     92.16      6,248,362     7.82        17,309     0.02             49,567 
      Share capital 
 9     reorganisation           73,605,664     92.12      6,233,362     7.80        65,388     0.08             38,050 
      Amendments to 
      Articles of 
 10   Association               73,558,743     92.16      6,248,513     7.82        17,158     0.02             88,050 
 11   Name change               73,605,664     92.17      6,233,362     7.81        15,388     0.02             88,050 
 

For further information please contact:

 
             Ark Therapeutics Group plc                        Tel: +44(0)203 755 5160 
             Iain G Ross, Non-Executive Chairman 
             Sue Steven, Non-Executive Director 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ROMBDBDDBSBBGSB

1 Year Premier Veterinary Chart

1 Year Premier Veterinary Chart

1 Month Premier Veterinary Chart

1 Month Premier Veterinary Chart

Your Recent History

Delayed Upgrade Clock